Your browser doesn't support javascript.
loading
Factors associated with outcomes after a second CD19-targeted CAR T-cell infusion for refractory B-cell malignancies.
Gauthier, Jordan; Bezerra, Evandro D; Hirayama, Alexandre V; Fiorenza, Salvatore; Sheih, Alyssa; Chou, Cassie K; Kimble, Erik L; Pender, Barbara S; Hawkins, Reed M; Vakil, Aesha; Phi, Tinh-Doan; Steinmetz, Rachel N; Jamieson, Abby W; Bar, Merav; Cassaday, Ryan D; Chapuis, Aude G; Cowan, Andrew J; Green, Damian J; Kiem, Hans-Peter; Milano, Filippo; Shadman, Mazyar; Till, Brian G; Riddell, Stanley R; Maloney, David G; Turtle, Cameron J.
Afiliação
  • Gauthier J; Clinical Research Division and.
  • Bezerra ED; Integrated Immunotherapy Research Center, Fred Hutchinson Cancer Research Center, Seattle, WA; and.
  • Hirayama AV; Department of Medicine and.
  • Fiorenza S; Department of Medicine and.
  • Sheih A; Clinical Research Division and.
  • Chou CK; Clinical Research Division and.
  • Kimble EL; Clinical Research Division and.
  • Pender BS; Clinical Research Division and.
  • Hawkins RM; Department of Pediatrics, University of Washington, Seattle, WA.
  • Vakil A; Clinical Research Division and.
  • Phi TD; Clinical Research Division and.
  • Steinmetz RN; Clinical Research Division and.
  • Jamieson AW; Clinical Research Division and.
  • Bar M; Clinical Research Division and.
  • Cassaday RD; Clinical Research Division and.
  • Chapuis AG; Clinical Research Division and.
  • Cowan AJ; Clinical Research Division and.
  • Green DJ; Integrated Immunotherapy Research Center, Fred Hutchinson Cancer Research Center, Seattle, WA; and.
  • Kiem HP; Department of Medicine and.
  • Milano F; Clinical Research Division and.
  • Shadman M; Department of Medicine and.
  • Till BG; Clinical Research Division and.
  • Riddell SR; Integrated Immunotherapy Research Center, Fred Hutchinson Cancer Research Center, Seattle, WA; and.
  • Maloney DG; Department of Medicine and.
  • Turtle CJ; Clinical Research Division and.
Blood ; 137(3): 323-335, 2021 01 21.
Article em En | MEDLINE | ID: mdl-32967009

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfoma não Hodgkin / Leucemia de Células B / Leucemia Linfocítica Crônica de Células B / Imunoterapia Adotiva / Antígenos CD19 / Leucemia-Linfoma Linfoblástico de Células Precursoras Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfoma não Hodgkin / Leucemia de Células B / Leucemia Linfocítica Crônica de Células B / Imunoterapia Adotiva / Antígenos CD19 / Leucemia-Linfoma Linfoblástico de Células Precursoras Idioma: En Ano de publicação: 2021 Tipo de documento: Article